Irlanda - inglês - HPRA (Health Products Regulatory Authority)

eli lilly nederland b.v. - human insulin (recombinant dna origin) - solution for injection in cartridge - 100 international unit(s)/millilitre - insulin (human)

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - human insulin (recombinant dna origin) - suspension for injection - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting; insulin (human)

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 70 iu/ml; isophane insulin, human 30 iu/ml - solution for injection - active: insulin, human, recombinant dna origin 70 iu/ml isophane insulin, human 30 iu/ml

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) excipient: dibasic sodium phosphate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml;  ; neutral insulin, human, pyr 30 iu/ml;   - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 70 iu/ml   neutral insulin, human, pyr 30 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride - treatment of diabetes mellitus.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml;  ; neutral insulin, human, pyr 30 iu/ml;   - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 70 iu/ml   neutral insulin, human, pyr 30 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 100 iu/ml;   - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 100 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 100 iu/ml;   - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 100 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting - humulin m3 - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - human insulin (recombinant dna origin) - suspension for injection - 100 iu/ml - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting - humulin m3 - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis.